Edition:
United States

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.99USD
18 Dec 2018
Change (% chg)

$-0.06 (-5.33%)
Prev Close
$1.05
Open
$1.06
Day's High
$1.07
Day's Low
$0.91
Volume
122,127
Avg. Vol
94,611
52-wk High
$3.30
52-wk Low
$0.47

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 0.172
Jun '18 0.00 -0.200
Mar '18 0.00 0.057
FY 2017 Dec '17 0.00 -0.437
Sep '17 0.00 -0.217
Jun '17 0.00 -0.117
Mar '17 0.00 -0.599
FY 2016 Dec '16 0.00 -0.367
Sep '16 0.00 -0.303
Jun '16 0.00 -0.392
Mar '16 0.00 -0.541
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.12 -0.12 -0.12 --
Year Ending Dec-18 1 -0.47 -0.47 -0.47 -0.98
Year Ending Dec-19 1 -0.52 -0.52 -0.52 -1.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -0.31 0.66 0.95
Price to Sales (TTM) -- 242.95 21.76
Price to Book (MRQ) 13.92 18.87 4.53
Price to Tangible Book (MRQ) 13.92 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 179.33 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 68.58 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 2.48 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -1.76 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -- -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -- -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -- -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 28,103,806 878,349,382
Net Income/Employee (TTM) -- -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.00 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.35 0.35 11.06
Return on Assets - 5 Yr. Avg. -197.07 2.90 11.85
Return on Investment (TTM) -83.36 0.60 13.80
Return on Investment - 5 Yr. Avg. -320.23 2.87 15.17
Return on Equity (TTM) -208.49 -2.18 15.29
Return on Equity - 5 Yr. Avg. -506.98 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 11.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellerophon Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 20.26 20.28 99 99
13 Week 14.04 23.20 99 94
26 Week -58.60 -58.48 25 96
52 Week -45.84 -47.47 57 98
YTD -63.90 -64.01 34 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.41%
# of Holders: 37
Total Shares Held: 36,623,050
3 Mo. Net Change: 801,269
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 15
# Reduced Positions: 11
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.